GRIN2A and schizophrenia: Convergent genetic evidence for GRIN2A as a schizophrenia susceptibility gene provides strong support for long-held (hypo-) glutamatergic theories of the disorder that were based on the observed induction of positive, negative, and cognitive symptoms in healthy adults after NMDA receptor antagonism (13,101).